MedTrace Logo

ReSure Sealant Post Approval Study

NCT02310815 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 626

Last updated 2016-12-05

No results posted yet for this study

Summary

This is a prospective multicenter observational post-approval registry study that will collect post-approval data relative to the incidence of pre-specified Adverse Ocular Events for cataract surgery patients treated with the FDA-approved ReSure Sealant when used by a broad group of physicians under commercial use conditions.

Conditions

  • Adverse Events

Interventions

DEVICE

ReSure Sealant

Sponsors & Collaborators

  • Ocular Therapeutix, Inc.

    lead INDUSTRY

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2016-02-29
Completion
2016-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02310815 on ClinicalTrials.gov